|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.100 USD | +1.57% |
|
+2.03% | -2.50% |
| 06-18 | Fat, not muscle: Drugmakers in race for next weight-loss breakthrough | RE |
| 05-23 | Altimmune, Inc., Q1 2025 Earnings Call, May 13, 2025 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 7.15 | 8.25 | 9.11 |
| Spread/Res. | -1.68% | -14.79% | -22.83% |
| Spread/Supp. | +16.97% | +91.55% | +65.80% |
| Support | 6.01 | 3.67 | 4.24 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ALT Stock
- Charts Altimmune, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition